Jamal Khader

[68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer

Nader Hirmas, Akram Al‐Ibraheem, Ken Herrmann et al. · Molecular Imaging and Biology · 2018 · 56 citations

Urology, High-risk Prostate Cancer, Genitourinary Cancer +7

Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Fady Geara, Muhammad Bulbul, Raja B. Khauli et al. · Radiation Oncology · 2017 · 33 citations · Full text

Multiple Primary Malignancies: Analysis of 23 Patients with at Least Three Tumors

Ahmed Salem, Ramiz Abu‐Hijlih, Fadwa Abdelrahman et al. · Journal of Gastrointestinal Cancer · 2011 · 24 citations

Tumoral Pathology, Malignant Disease, Medicine +8

Modification and Implementation of NCCN Guidelines™ on Non–Small Cell Lung Cancer in the Middle East and North Africa Region

Abdul Rahman Jazieh, Hanaa Bamefleh, Ahmet Demirkazık et al. · Journal of the National Comprehensive Cancer Network · 2010 · 23 citations · Full text

Lung Cancer Committee, Advanced Lung Disease, Cancer Management +19

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial

T. Konert, Wouter V. Vogel, Diana Páez et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 21 citations · Full text